Study of FXS5626 tablets and their effect on heart rhythm
Part of Heart & circulation clinical trials.
This trial tests how a new oral medication affects the heart's electrical activity. It is for healthy volunteers aged 18 to 45 to help ensure the drug is safe before testing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You are a healthy adult (no major medical conditions)
- Your BMI is between 19 and 28
- You weigh at least 110 lbs (50 kg) if male, or 99 lbs (45 kg) if female
- You are not pregnant, breastfeeding, or planning to donate sperm/eggs for 3 months after the last dose
- You agree to use effective contraception during the study and for 3 months after
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This trial tests whether a new drug called XY0206 affects the heart's electrical activity (QTc interval). Healthy participants take either XY0206, a placebo, or a control drug to compare effects. It helps ensure the drug is safe for the heart before testing in patients.
This study tests whether a new experimental medication called HDM1002 affects how your heart beats in a healthy population. Researchers want to make sure the drug is safe before testing it in patients with actual medical conditions.
This trial tests whether a new drug, JMKX003142, affects the heart's electrical activity (QTc interval) in healthy volunteers. It helps determine if the drug is safe for the heart before testing in patients.
This study tests whether a single dose of the drug JMKX001899 affects the heart's electrical activity (QTc interval) in healthy adults. It helps researchers understand the drug's safety before moving to larger studies.
This early-phase study tests a new oral tablet (YR011) in healthy volunteers to see how safe it is and how the body processes it. It helps find the right dose for future studies.
Hear when a new Evaluation of QTc Interval trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.